chartexchange

URGN
UroGen Pharma Ltd.
stockNASDAQ

Market OpenNov 19, 2026 9:53:18 AM EST
30.91USD+3.760%(+1.12)73,662
Pre-marketNov 19, 2026 8:31:30 AM EST
31.11USD+4.431%(+1.32)
26.75Bid34.91Ask8.16Spread

URGN Financials

In Q3 FY 2026 (ended ), UroGen Pharma Ltd. (URGN) reported revenue of $89M, net income of −$1.46M, operating cash flow of −$15.2M, and assets of $271.87M (filed ).

Loading business breakdowns…